Loading...

Odonate Therapeutics, Inc.

ODTCPNK
Healthcare
Biotechnology
$22005.00
$5005.00(29.44%)

Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview

Explore Odonate Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Odonate Therapeutics, Inc. (ODTC) Company Profile & Overview

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

SectorHealthcare
IndustryBiotechnology
CEOKevin C. Tang

Contact Information

332 206 0935
3 East 28th Street, New York City, NY, 10016

Company Facts

137 Employees
IPO DateDec 7, 2017
CountryUS

Frequently Asked Questions

;